Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 37

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 37
---
| • |     | the impairment of STAAR’s ability to attract, retain, and motivate STAAR’s employees, including key 
 personnel;                                                                                          |

| • |     | the diversion of significant management time and resources toward the completion of the Merger; |

| • |     | difficulties maintaining relationships with distributors, customers, suppliers, and other business partners; |

| • |     | delays or deferments of certain business decisions by STAAR’s distributors, customers, suppliers, and other 
 business partners;                                                                                          |

| • |     | the inability to pursue alternative business opportunities or make appropriate changes to STAAR’s business                                                                                                                    
 because the Merger Agreement requires STAAR to use commercially reasonable efforts to carry on STAAR’s business in the ordinary course and preserve intact STAAR’s material business organization and existing relationships; |

| • |     | litigation relating to the Merger and the costs related thereto; and |

| • |     | the incurrence of significant costs, expenses, and fees for professional services and other transaction costs in 
 connection with the Merger.                                                                                      |

The consummation of the Merger is subject to certain closing conditions, including adoption of the Merger Agreement by STAAR stockholders and certain regulatory conditions, which may not be satisfied on a timely basis or at all, and the failure to consummate the Merger within the expected timeframe or at all could adversely impact STAAR’s business, financial condition, and results of operations. The obligations of STAAR, Alcon and Merger Sub to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver of a number of conditions, including the adoption of the Merger Agreement by holders of a majority of the outstanding shares of STAAR common stock entitled to vote thereon. Ownership of STAAR common stock is currently concentrated among a few stockholders, and STAAR’s largest stockholder, Broadwood Partners, L.P. (“Broadwood”), reported beneficial ownership as of August 8, 2025 of approximately 27.3% of STAAR’s outstanding shares of STAAR common stock. On September 2, 2025, Broadwood filed a Schedule 13D/A and issued a related press release indicating, among other things, that it intends to vote against the Merger Proposal. On September 15, 2025, Broadwood and other members of the Broadwood Group filed a preliminary proxy statement with the SEC to solicit votes of STAAR -23-

stockholders in opposition to the